Best Prostate Cancer Treatment Specialist in Mumbai
- Home
- Best Prostate Cancer Treatment Specialist in Mumbai
Prostate cancer is one of the most common cancers in men over 50 in India, yet the decision of how to treat it is rarely straightforward. For localised prostate cancer, a man may be appropriately advised to choose between surgery, radiation therapy, brachytherapy, or even active surveillance. For locally advanced disease, radiation combined with hormone therapy is the standard approach.
For metastatic prostate cancer, hormone therapy, novel anti-androgen agents, and chemotherapy are coordinated over months and years. Each treatment path requires a different specialist, and finding a team in Mumbai where all three work together on the same case is harder than it sounds.
Onco-Life Cancer Centre at Talegaon, 70 to 75 km from Mumbai via the Expressway, has a surgical oncologist, a radiation oncologist, and a medical oncologist who review prostate cancer cases together at the Tumour Board before any treatment is recommended. We offer radical prostatectomy, SBRT (Stereotactic Body Radiotherapy) and IMRT for radiation, low-dose rate seed brachytherapy and high-dose rate brachytherapy, hormone therapy (ADT) and novel anti-androgens, and chemotherapy for castration-resistant disease. For Mumbai men with a new prostate cancer diagnosis, or those seeking a second opinion before committing to a treatment decision, Onco-Life is accessible in 75 to 90 minutes without the waiting times common at busy Mumbai oncology departments.
Why Mumbai Patients Choose Onco-Life for Prostate Cancer Treatment
A Specialist Prostate Cancer Team, Not a Single Consultant
The treatment recommendation for prostate cancer should come from a team, not a single specialist. A urologist who only performs surgery, or a radiation oncologist who only treats with radiation, is not ideally placed to give an impartial recommendation between surgery, radiation, brachytherapy, and active surveillance. At Onco-Life, the surgical, radiation, and medical oncologists review every prostate cancer case at our Tumour Board before any treatment is recommended. The patient then hears the joint recommendation of all three, with the reasoning explained clearly. This multidisciplinary approach is standard at leading cancer centres internationally, and it is how every prostate cancer case is managed at Onco-Life.
Accessible from Mumbai in Under 90 Minutes
Our Talegaon centre is 70 to 75 km from Mumbai via the Expressway, about 75 to 90 minutes from most parts of the city. Many Mumbai patients with prostate cancer travel to Talegaon for hormone therapy injections, radiation sessions, and post-operative follow-up visits and return home the same day. For men undergoing a full course of IMRT or SBRT radiation, the accessibility of the centre makes the entire 5-week or 2-week treatment course far more manageable than commuting across Mumbai to a city-centre hospital.
NABH Accreditation and Full Prostate Cancer Technology
Onco-Life holds three NABH (National Accreditation Board for Hospitals and Healthcare Providers) accreditations. For prostate cancer patients, our technology includes:
- SBRT capability: delivering high-dose, highly focused radiation to the prostate in 5 sessions with sub-millimetre accuracy
- IMRT and IGRT: the standard external beam approach for prostate cancer, with daily positioning verification
- Brachytherapy: internal radiation for eligible prostate cancer patients
- PET-CT Scan: for staging and post-treatment surveillance
- Surgical oncology suites for radical prostatectomy
- Virtual Tumour Board review for every case before treatment is recommended
All Prostate Cancer Stages Treated
From a PSA elevation detected at routine health check through to castration-resistant metastatic disease, Onco-Life manages every stage of prostate cancer. We counsel on active surveillance for eligible low-risk patients. We perform surgery and radiation for localised and locally advanced disease. We manage hormone therapy, novel anti-androgens, and chemotherapy for advanced and metastatic cases. A patient does not need to change hospitals as their disease stage changes.
Prostate Cancer Treatment Cost in Mumbai
Prostate cancer treatment cost in Mumbai varies significantly by treatment type, hospital, and disease stage. At major private hospitals in the city, radical prostatectomy typically ranges from Rs 2.5 lakh to Rs 6 lakh. A full course of IMRT radiation costs Rs 1.5 lakh to Rs 3.5 lakh at private centres. SBRT for prostate cancer (5 sessions) is typically Rs 1.5 lakh to Rs 2.5 lakh. Hormone therapy (LHRH agonist injections every 3 months) costs Rs 8,000 to Rs 25,000 per injection depending on the drug. Novel anti-androgens (enzalutamide, abiraterone) for metastatic castration-resistant disease are among the more expensive elements of prostate cancer management.
At Onco-Life, treatment costs are transparent. For self-paying patients, we provide a written cost estimate before treatment begins, broken down by modality. For patients eligible under MJPJAY and PM-JAY, prostate cancer surgery and radiation therapy packages may be covered at no out-of-pocket cost. Call us with your PSA level, biopsy findings, and stage, and we will outline expected costs and any applicable coverage before your first visit.
Comprehensive Prostate Cancer Treatment at Onco-Life
Surgical Oncology: Radical Prostatectomy
Radical prostatectomy, the complete surgical removal of the prostate gland, is the primary surgical treatment for localised prostate cancer in patients with adequate health and life expectancy. At Onco-Life, our surgical oncologist performs:
- Open radical retropubic prostatectomy: the established surgical approach for complete prostate and seminal vesicle removal with bilateral pelvic lymph node dissection where indicated
- Nerve-sparing radical prostatectomy: preserving the neurovascular bundles on one or both sides where oncologically appropriate, to reduce the impact on erectile function and urinary control
- Extended pelvic lymph node dissection: in patients with intermediate or high-risk localised prostate cancer where nodal staging is clinically significant
The surgical recommendation at Onco-Life comes after a Tumour Board review. Every eligible patient is counselled on both surgery and radiation before a treatment decision is made.
Radiation Oncology: SBRT, IMRT, and Brachytherapy for Prostate Cancer
Radiation therapy for prostate cancer has advanced significantly over the past decade. At Onco-Life, we offer:
- SBRT (Stereotactic Body Radiotherapy): delivers the full radiation prescription in 5 sessions over 1 to 2 weeks with sub-millimetre precision. SBRT is now an established, guideline-endorsed option for low and intermediate-risk localised prostate cancer. Each session is image-guided, tracking the prostate position to within millimetres.
- IMRT and IGRT: Intensity-Modulated Radiation Therapy delivered over 20 to 28 sessions with daily image guidance. The standard external beam approach for prostate cancer at most centres, offering robust tumour coverage while protecting the rectum and bladder.
- Brachytherapy: internal radiation for eligible low and intermediate-risk prostate cancer. High-dose rate (HDR) brachytherapy is used as monotherapy or as a boost following EBRT. This approach delivers high doses directly to the prostate while protecting surrounding structures.
- Post-prostatectomy radiation: salvage radiation therapy for patients with PSA rise after radical prostatectomy, targeting the prostate bed and regional nodes.
- Hormone therapy combined with radiation: androgen deprivation therapy (ADT) added to radiation for intermediate and high-risk localised and locally advanced prostate cancer, following evidence-based protocols.
Medical Oncology: Hormone Therapy and Treatment for Advanced Prostate Cancer
Advanced and metastatic prostate cancer management has changed substantially with newer hormonal agents and their established role in earlier disease stages. Our medical oncologists prescribe and manage:
- LHRH agonists (goserelin, leuprorelin, degarelix) for androgen deprivation therapy: standard hormone therapy given as injections every 1, 3, or 6 months for locally advanced and metastatic prostate cancer
- Anti-androgens (bicalutamide, enzalutamide): prescribed alone or in combination with LHRH agonists for complete androgen blockade or for castration-resistant disease
- Novel anti-androgen therapy: enzalutamide and abiraterone acetate for metastatic castration-resistant prostate cancer (mCRPC) and, increasingly, for earlier-stage metastatic disease
- Docetaxel chemotherapy: for patients with metastatic castration-resistant prostate cancer where hormonal agents are no longer effective
- Bone-protective agents: zoledronic acid and denosumab for patients with bone metastases to reduce skeletal events
PSA monitoring and imaging surveillance guide every treatment phase change. Our team reviews results and adjusts protocols proactively.
PET-CT Scan and Prostate Cancer Staging
Accurate staging before prostate cancer treatment begins determines whether the disease is localised, regionally spread, or metastatic. For newly diagnosed high-risk or locally advanced prostate cancer, imaging to assess pelvic lymph nodes and bone involvement is essential before surgery or radiation is planned. At Onco-Life, PET-CT Scan is available at Talegaon and Pune. Results are reviewed directly by the treating oncologist in the context of PSA, Gleason score, and clinical stage.
Active Surveillance for Low-Risk Prostate Cancer
Not all prostate cancers need immediate treatment. For men with very low or low-risk localised prostate cancer (PSA under 10, Gleason score 6 or Gleason Grade Group 1, limited-volume disease on biopsy), active surveillance is a legitimate and guideline-recommended management strategy. A prostate cancer specialist in Mumbai can help determine whether active surveillance is the most appropriate option based on your individual risk profile.
Active surveillance involves regular PSA testing, digital rectal examination, and periodic repeat biopsy to monitor for disease progression. Treatment is initiated only if the disease shows signs of progression. Our Tumour Board and prostate cancer specialist in Mumbai counsel eligible patients on active surveillance as one of the treatment options, ensuring the decision is informed and not driven solely by a preference for immediate intervention.
Multidisciplinary Tumour Boards
Every prostate cancer case at Onco-Life goes to the Tumour Board before a treatment recommendation is made. This is particularly important for prostate cancer, where the choice between surgery and radiation has significant quality-of-life implications. The surgical oncologist, radiation oncologist, and medical oncologist review the PSA level, Gleason score, staging imaging, patient age, comorbidities, and personal preferences together. The result is one coordinated recommendation, not competing opinions from specialists each advocating for their own modality.
Meet Our Prostate Cancer Specialist Team
Your Prostate Cancer Care Journey at Onco-Life
Step 1: Initial Consultation and Biopsy Review
You meet with our prostate cancer specialist who reviews your PSA history, digital rectal examination findings, prostate biopsy report (Gleason score, number of cores involved, percentage of each core involved), and any existing imaging. We explain your risk category clearly and outline what additional staging investigations are needed.
Step 2: Staging and Risk Stratification
Based on PSA level, Gleason score, and clinical stage, we determine your risk category (very low, low, intermediate, or high risk) and arrange appropriate staging imaging. This guides whether the disease requires local treatment only or combined local and systemic treatment.
Step 3: Tumour Board and Treatment Options
Your case goes to the Tumour Board. The joint recommendation from the surgical, radiation, and medical oncologists is presented to you with the reasoning explained: why surgery or radiation is recommended, what the alternatives are, what active surveillance would involve, and how side effect profiles differ between options. You make the treatment decision with full information.
Step 4: Treatment Delivery and PSA Monitoring
Treatment is delivered at Onco-Life Talegaon. PSA is monitored at regular intervals throughout and after treatment. For radiation patients, PSA nadirs are tracked. For surgical patients, PSA should become undetectable. For hormone therapy patients, PSA response and testosterone levels are monitored. Any sign of treatment failure triggers early review and adjustment.
Step 5: Long-Term Surveillance
Prostate cancer surveillance continues for years after initial treatment. PSA testing every 6 months for the first 2 years, then annually. Imaging at defined intervals or at PSA rise. For patients on long-term ADT, bone density monitoring and metabolic management are part of the ongoing care plan. We stay with you through the surveillance period.
Why Choose Onco-Life for Prostate Cancer Treatment in Mumbai?
Mumbai has hospitals with urology and oncology departments. Onco-Life is a dedicated cancer centre where prostate cancer is managed by a team that includes all three relevant specialists. The differences that matter:
- Multidisciplinary Tumour Board review before treatment is recommended
- All three treatment modalities: surgery, radiation, and hormone therapy under one team
- SBRT for prostate cancer in 5 sessions with sub-millimetre precision
- IMRT, IGRT, and brachytherapy for prostate radiation
- Nerve-sparing radical prostatectomy for eligible patients
- Active surveillance counselling for low-risk disease
- Novel anti-androgen therapy: enzalutamide, abiraterone for castration-resistant disease
- PET-CT Scan and bone imaging at the same facility
- Three NABH accreditations
- National Cancer Grid member – protocols aligned with Tata Memorial Centre
- Accessible from Mumbai in 75 to 90 minutes via the Expressway
- Transparent prostate cancer treatment costs before you begin
Government Scheme Coverage for Prostate Cancer Treatment
Mumbai patients who hold an MJPJAY (Mahatma Jyotiba Phule Jan Arogya Yojana) or PM-JAY (Ayushman Bharat) card may have prostate cancer surgery, radiation therapy, and certain medical oncology packages covered at Onco-Life at no out-of-pocket cost. CGHS and ECHS beneficiaries are also accepted. Call us with your scheme details and diagnosis and our Arogya Mitra coordinators will confirm coverage for your specific stage and treatment plan before you travel.
Accessing Onco-Life Cancer Centre from Mumbai
Talegaon (Nearest Centre to Mumbai – 75 to 90 Minutes)
Our Talegaon centre is the closest Onco-Life facility for Mumbai patients, located on the Mumbai-Pune Expressway corridor. From South Mumbai, Central Mumbai, and the western and eastern suburbs, the Expressway journey is typically 75 to 90 minutes. Full prostate cancer services are available here: PET-CT Scan, surgical oncology, SBRT and IMRT radiation, brachytherapy, hormone therapy injections, and medical oncology.
Wagholi, Pune (approximately 90 to 105 minutes from Mumbai)
Our Wagholi centre near Pune is accessible by car or by train to Pune followed by a short cab ride. Medical oncology, PET-CT Scan, and full diagnostic services are available here. Patients from parts of Mumbai who prefer the Pune route can access prostate cancer services at this centre.
Telemedicine Before You Travel
If you have a prostate biopsy report, PSA history, and staging imaging, our specialist can review your case by video. Share your reports digitally and we will confirm your risk category, what treatment options apply, and whether an in-person visit is immediately needed. Many patients use telemedicine for the initial assessment and come in for treatment once the plan is agreed.
Add the map here for Mumbai location for treatment like this
Book Your Consultation Today
Prostate cancer at early or localised stage carries a much broader range of treatment options than at advanced stage. A prompt consultation, staging, and Tumour Board review gives you the clearest picture of your options before any decision is made. Onco-Life's prostate cancer team is accessible from Mumbai in under 90 minutes. We are ready to see you, review your reports, and give you a coordinated specialist recommendation.
Ready to take the next step?
- Call Talegaon (Nearest to Mumbai): 8128124067, 8128123067
- Call Pune / Wagholi: 8128124067, 8128123067
- Call Satara: 02162-350063, 7769004343, 7030362222
- Call Chiplun: 7378958000, 9404240762
- Book Online: https://oncolifehospitals.com/book-doctor-appointment/
- Telemedicine Consultation: Speak with a prostate cancer specialist online
We are here for you. Specialist prostate cancer care with all treatment options is accessible from Mumbai. Let us help you make the right decision for your specific case.
Frequently Asked Questions
Best Prostate Cancer Treatment Specialist in Mumbai-FAQs
Is Onco-Life accessible from Mumbai for prostate cancer treatment?
Yes. Our Talegaon centre is 70 to 75 km from Mumbai, about 75 to 90 minutes by car via the Expressway. Telemedicine is available for an initial case review before travelling.
What is prostate cancer treatment cost at Onco-Life?
For self-paying patients, we provide transparent written cost estimates before treatment begins. MJPJAY and PM-JAY eligible patients may have surgery, radiation, and related packages covered at no cost. Call us with your stage and proposed treatment plan and we will outline costs clearly before your first visit.
Should I choose surgery or radiation for my prostate cancer?
The choice between surgery and radiation depends on factors such as PSA level, tumour stage, age, overall health, and personal preferences. Both offer similar cancer control for many patients, but side effects differ. Our Tumour Board explains all options and helps you make an informed decision.
What is SBRT for prostate cancer?
SBRT (Stereotactic Body Radiotherapy) delivers highly precise radiation to the prostate in just 5 sessions over 1–2 weeks. It is a guideline-endorsed treatment for low- and intermediate-risk localised prostate cancer, offering effective treatment with minimal disruption to daily life.
Do I need a referral to see a prostate cancer specialist at Onco-Life?
No referral is needed. Come directly with your PSA reports, biopsy findings, and any existing imaging. If you have a PSA elevation or suspicious finding but no biopsy yet, we will coordinate the investigation.
Is active surveillance an option for prostate cancer at Onco-Life?
Yes. For eligible men with very low- or low-risk localised prostate cancer, active surveillance is an option. It involves regular PSA tests, clinical evaluations, and periodic biopsies, with treatment started only if the cancer shows signs of progression.
MBBS, MS (General Surgery)
Senior Consultant – Surgical Oncology
Onco-Life Cancer Centre, Satara
Veteran Surgical Oncologist with 23+ Years of Experience